. 2014 Feb;4(2):143–151. doi: 10.1016/S2221-1691(14)60223-9

Table 4. Inhibitory effect of ACP on FeCl₂-ascorbic acid-induced lipid peroxidation in rat liver homogenate in vitro.

Treatments	ACP (µg/mL)	MDA (nmol/g wet liver)	MDA inhibition (%)
Normal control	-	1.21±0.40^c	-
FeCl₂-AA	-	2.56±0.15^e	-
FeCl₂-AA+ACP	25	2.12±0.06^d	17.19^a
FeCl₂-AA+ACP	50	1.99±0.05^b	22.27^b
FeCl₂-AA+ACP	75	0.88±0.02^a	65.63^c
FeCl₂-AA+ACP	100	0.81±0.04^a	68.36^c

Values are the mean±SD, n=3, analysis of variance (ANOVA) followed by Duncan's multiple range test, means bearing different superscripts differ significantly (P≤0.01). AA: Ascorbic acid.

Table 4. Inhibitory effect of ACP on FeCl2-ascorbic acid-induced lipid peroxidation in rat liver homogenate in vitro.

Table 4. Inhibitory effect of ACP on FeCl₂-ascorbic acid-induced lipid peroxidation in rat liver homogenate in vitro.